Lung cancers attract circulating immune cells to the tumor mass, where the cancer reprograms them to support its growth and progression, researchers from Weill Cornell Medical College have found.
The National Institutes of Health's National Institute of Biomedical Imaging and Bioengineering has awarded Cornell a four-year, $2.3 million grant to develop FeverPhone, which will diagnose six febrile diseases in the field.
Using a technique that illuminates subtle changes in individual proteins, chemistry researchers have uncovered new insight into the underlying causes of Amyotrophic Lateral Sclerosis.
Patients who develop bacterial endocarditis have an elevated risk of stroke beginning four months before, and up to five months after diagnosis – a period significantly longer than previously reported.
Dr. Silvia C. Formenti, an international expert in the use of radiation therapy for the treatment of cancer, has been appointed chair of the newly established Department of Radiation Oncology at Weill Cornell Medical College.
A Weill Cornell Medicine investigators suggests a lung function test frequently to evaluate whether a smoker is at risk for developing pulmonary disease is likely mislabeling smokers as healthy.
Cornell University's Atkinson Center for a Sustainable Future and Environmental Defense Fund announced four new research projects addressing pressing health and environmental issues Nov. 9. The projects mark the official launch of a new partnership between the two institutions.
Juan Hinestroza and his students live in a cotton-soft nano world, where they create clothing that kills bacteria, conducts electricity, wards off malaria, captures harmful gas and weaves transistors into shirts and dresses.
Weill Cornell Medicine researchers have found a new therapeutic approach to an aggressive form of lymphoma that may greatly increase the efficacy of treatment and result in better patient outcomes.